부산대학교 도서관

Hemminki, K.; Kiemeney, L.A.L.M.; Morgans, A.K.; Ranniko, A.; Pichler, R.; Hemminki, O.; Culig, Z.; Mulders, P.; Bangma, Chris H.

Eur Urol Open Sci
European Urology Open Science, Vol 69, Iss, Pp 13-20 (2024)
European Urology Open Science, 69, pp. 13-20

Pakola SA; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Ojala N; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Kudling TV; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Clubb JHA; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; TILT Biotherapeutics Ltd, Helsinki, Finland.; Jirovec E; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; van der Heijden M; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Arias V; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Haybout L; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; TILT Biotherapeutics Ltd, Helsinki, Finland.; Basnet S; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Grönberg-Vähä-Koskela S; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.; Quixabeira DCA; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; TILT Biotherapeutics Ltd, Helsinki, Finland.; Santos JM; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; TILT Biotherapeutics Ltd, Helsinki, Finland.; Cervera-Carrascon V; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; TILT Biotherapeutics Ltd, Helsinki, Finland.; Hemminki O; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Department of Urology, Helsinki University Hospital, Helsinki, Finland.; Kanerva A; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Department of Gynecology and Obstetrics, Helsinki University Hospital, Helsinki, Finland.; Mustonen H; Department of Surgery, Translational Cancer Medicine Research Program and ICAN Digital Precision Cancer Medicine Flagship, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Puolakkainen P; Department of Surgery, Translational Cancer Medicine Research Program and ICAN Digital Precision Cancer Medicine Flagship, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Seppänen H; Department of Surgery, Translational Cancer Medicine Research Program and ICAN Digital Precision Cancer Medicine Flagship, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Hemminki A; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland. akseli.hemminki@helsinki.fi.; TILT Biotherapeutics Ltd, Helsinki, Finland. akseli.hemminki@helsinki.fi.; Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland. akseli.hemminki@helsinki.fi.

Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE

Jalanko, T.; Sammaltupa, H.; Koskinen, I.; Vasarainen, H.; Hemminki, O.; Sairanen, J.

European Urology. 87:S1565-S1565

Tichanek F; Försti A; Hemminki O; Hemminki A; Hemminki K

Clinical Epidemiology, Vol 15, Pp 503-510 (2023)

Hemminki, O; Parviainen, S; Juhila, J; Turkki, R; Linder, N; Lundin, J; Kankainen, M; Ristimaki, A; Koski, A; Liikanen, I

ONCOTARGET. 6(6):4467-4481

Clubb JHA; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, 00290 Helsinki, Finland; TILT Biotherapeutics, 00290 Helsinki, Finland.; Pakola SA; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, 00290 Helsinki, Finland.; Joenväärä S; Transplantation Laboratory, Faculty of Medicine, University of Helsinki, Helsinki, Finland; HUSLAB, Helsinki University Hospital, 00290 Helsinki, Finland.; Kudling TV; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, 00290 Helsinki, Finland; TILT Biotherapeutics, 00290 Helsinki, Finland.; Tohmola T; Transplantation Laboratory, Faculty of Medicine, University of Helsinki, Helsinki, Finland; HUSLAB, Helsinki University Hospital, 00290 Helsinki, Finland.; Arias V; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, 00290 Helsinki, Finland.; Jirovec E; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, 00290 Helsinki, Finland.; van der Heijden M; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, 00290 Helsinki, Finland.; Quixabeira DCA; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, 00290 Helsinki, Finland; TILT Biotherapeutics, 00290 Helsinki, Finland.; Pasanen A; Department of Pathology, University of Helsinki and Helsinki University Hospital, 00290 Helsinki, Finland.; Haybout L; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, 00290 Helsinki, Finland; TILT Biotherapeutics, 00290 Helsinki, Finland.; Ojala N; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, 00290 Helsinki, Finland.; Basnet S; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, 00290 Helsinki, Finland.; Eleuteri A; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, 00290 Helsinki, Finland.; Ferrero JD; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, 00290 Helsinki, Finland.; Hirvenoja S; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, 00290 Helsinki, Finland.; Svane IM; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, 2730 Herlev, Denmark.; Mäenpää J; Docrates Cancer Center, 00180 Helsinki, Finland.; Jalkanen K; Comprehensive Cancer Center, Helsinki University Hospital, 00290 Helsinki, Finland.; Block MS; Mayo Clinic Cancer Center, Rochester, MN 55905, USA.; Alanko T; Docrates Cancer Center, 00180 Helsinki, Finland.; Monberg T; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, 2730 Herlev, Denmark.; Zahraoui S; TILT Biotherapeutics, 00290 Helsinki, Finland.; Grönberg-Vähä-Koskela S; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, 00290 Helsinki, Finland; Comprehensive Cancer Center, Helsinki University Hospital, 00290 Helsinki, Finland.; Salmelin N; IRCM, Insitute de Reserche en Cancérologie de Monpellier, INSERM U1194, University Montpellier, Institute Régional du Cancer Montpellier, Montpellier, France.; Kistler C; TILT Biotherapeutics, 00290 Helsinki, Finland.; Havunen R; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, 00290 Helsinki, Finland; TILT Biotherapeutics, 00290 Helsinki, Finland.; Sorsa S; TILT Biotherapeutics, 00290 Helsinki, Finland.; Manuel Dos Santos J; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, 00290 Helsinki, Finland; TILT Biotherapeutics, 00290 Helsinki, Finland.; Cervera-Carrascon V; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, 00290 Helsinki, Finland; TILT Biotherapeutics, 00290 Helsinki, Finland.; Kanerva A; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, 00290 Helsinki, Finland; Department of Obstetrics and Gynecology, Helsinki University Hospital and University of Helsinki, 00290 Helsinki, Finland.; Hemminki O; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, 00290 Helsinki, Finland; Department of Urology, Helsinki University Hospital, 00290 Helsinki, Finland.; Renkonen R; Transplantation Laboratory, Faculty of Medicine, University of Helsinki, Helsinki, Finland; HUSLAB, Helsinki University Hospital, 00290 Helsinki, Finland.; Hemminki A; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, 00290 Helsinki, Finland; TILT Biotherapeutics, 00290 Helsinki, Finland; Comprehensive Cancer Center, Helsinki University Hospital, 00290 Helsinki, Finland. Electronic address: akseli.hemminki@helsinki.fi.

Publisher: Cell Press Country of Publication: United States NLM ID: 100890581 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-0024 (Electronic) Linking ISSN: 15250016 NLM ISO Abbreviation: Mol Ther Subsets: MEDLINE

Hemminki, O; Perlis, N; Bjorklund, J; Finelli, A; Zlotta, AR; Hemminki, A

EUROPEAN UROLOGY OPEN SCIENCE. 22:61-73

Hemminki K; Biomedical Center, Faculty of Medicine, Charles University, Pilsen, 30605, Czech Republic. k.hemminki@dkfz.de.; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, D-69120, Heidelberg, Germany. k.hemminki@dkfz.de.; Hemminki O; Department of Urology, Helsinki University Hospital, Helsinki, Finland.; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.; Koskinen A; Department of Otorhinolaryngology- Head and Neck Surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.; Skin and Allergy Hospital, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.; Hemminki A; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.; Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland.; Försti A; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.

Publisher: BioMed Central Country of Publication: Poland NLM ID: 101231179 Publication Model: Electronic Cited Medium: Print ISSN: 1731-2302 (Print) Linking ISSN: 17312302 NLM ISO Abbreviation: Hered Cancer Clin Pract Subsets: PubMed not MEDLINE

Hemminki K; Biomedical Center, Faculty of Medicine, Charles University, Pilsen, 30605, Czech Republic. k.hemminki@dkfz.de.; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, Heidelberg, 69120, Germany. k.hemminki@dkfz.de.; Försti A; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Cancer Consortium (DKTK), Heidelberg, Germany.; Hemminki O; Department of Urology, Helsinki University Hospital, Helsinki, Finland.; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.; Scott RJ; The University of Newcastle, Callaghan, NSW, Australia.; Hunter Medical Research Institute, New Lambton, NSW, Australia.; Hemminki A; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.; Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland.

Publisher: BioMed Central Country of Publication: Poland NLM ID: 101231179 Publication Model: Electronic Cited Medium: Print ISSN: 1731-2302 (Print) Linking ISSN: 17312302 NLM ISO Abbreviation: Hered Cancer Clin Pract Subsets: PubMed not MEDLINE

Kudling TV; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Bychkov D; Digital Diagnostics Group, Institute for Molecular Medicine Finland (FIMM), Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.; Clubb JHA; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; TILT Biotherapeutics Ltd, Helsinki, Finland.; Pakola SA; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Arias V; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Jirovec E; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; van der Heijden M; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Ojala N; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Quixabeira DCA; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; TILT Biotherapeutics Ltd, Helsinki, Finland.; Haybout L; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; TILT Biotherapeutics Ltd, Helsinki, Finland.; Jalkanen KJ; Comprehensive Cancer Center, Helsinki University Hospital (HUS), Helsinki, Finland.; Alanko T; Docrates Cancer Center, Helsinki, Finland.; Havunen R; TILT Biotherapeutics Ltd, Helsinki, Finland.; Sorsa S; TILT Biotherapeutics Ltd, Helsinki, Finland.; Kistler C; TILT Biotherapeutics Ltd, Helsinki, Finland.; Kanerva A; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Department of Obstetrics and Gynecology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.; Hemminki O; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Department of Urology, Helsinki University Hospital, Helsinki, Finland.; Santos JM; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; TILT Biotherapeutics Ltd, Helsinki, Finland.; Cervera-Carrascon V; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; TILT Biotherapeutics Ltd, Helsinki, Finland.; Hemminki A; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland. akseli.hemminki@helsinki.fi.; TILT Biotherapeutics Ltd, Helsinki, Finland. akseli.hemminki@helsinki.fi.; Comprehensive Cancer Center, Helsinki University Hospital (HUS), Helsinki, Finland. akseli.hemminki@helsinki.fi.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9432230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5500 (Electronic) Linking ISSN: 09291903 NLM ISO Abbreviation: Cancer Gene Ther Subsets: MEDLINE

Gissler, M; Rahkonen, O; Arntzen, A; Cnattingius, S; Andersen, A-M Nybo; Hemminki, E

Journal of Epidemiology and Community Health (1979-), 2009 Jun 01. 63(6), 420-425.

REGUSHEVSKAYA, E.; DUBIKAYTIS, T.; NIKULA, M.; KUZNETSOVA, O.; HEMMINKI, E.

Scandinavian Journal of Public Health, 2008 Mar 01. 36(2), 143-152.

Amand F. Schmidt; Michael V. Holmes; David Preiss; Daniel I. Swerdlow; Spiros Denaxas; Ghazaleh Fatemifar; Rupert Faraway; Chris Finan; Dennis Valentine; Zammy Fairhurst-Hunter; Fernando Pires Hartwig; Bernardo Lessa Horta; Elina Hypponen; Christine Power; Max Moldovan; Erik van Iperen; Kees Hovingh; Ilja Demuth; Kristina Norman; Elisabeth Steinhagen-Thiessen; Juri Demuth; Lars Bertram; Christina M. Lill; Stefan Coassin; Johann Willeit; Stefan Kiechl; Karin Willeit; Dan Mason; John Wright; Richard Morris; Goya Wanamethee; Peter Whincup; Yoav Ben-Shlomo; Stela McLachlan; Jackie F. Price; Mika Kivimaki; Catherine Welch; Adelaida Sanchez-Galvez; Pedro Marques-Vidal; Andrew Nicolaides; Andrie G. Panayiotou; N. Charlotte Onland-Moret; Yvonne T. van der Schouw; Giuseppe Matullo; Giovanni Fiorito; Simonetta Guarrera; Carlotta Sacerdote; Nicholas J. Wareham; Claudia Langenberg; Robert A. Scott; Jian’an Luan; Martin Bobak; Sofia Malyutina; Andrzej Pająk; Ruzena Kubinova; Abdonas Tamosiunas; Hynek Pikhart; Niels Grarup; Oluf Pedersen; Torben Hansen; Allan Linneberg; Tine Jess; Jackie Cooper; Steve E. Humphries; Murray Brilliant; Terrie Kitchner; Hakon Hakonarson; David S. Carrell; Catherine A. McCarty; Kirchner H. Lester; Eric B. Larson; David R. Crosslin; Mariza de Andrade; Dan M. Roden; Joshua C. Denny; Cara Carty; Stephen Hancock; John Attia; Elizabeth Holliday; Rodney Scott; Peter Schofield; Martin O’Donnell; Salim Yusuf; Michael Chong; Guillaume Pare; Pim van der Harst; M. Abdullah Said; Ruben N. Eppinga; Niek Verweij; Harold Snieder; Lifelines Cohort authors; Tim Christen; D. O. Mook-Kanamori; the ICBP Consortium; Stefan Gustafsson; Lars Lind; Erik Ingelsson; Raha Pazoki; Oscar Franco; Albert Hofman; Andre Uitterlinden; Abbas Dehghan; Alexander Teumer; Sebastian Baumeister; Marcus Dörr; Markus M. Lerch; Uwe Völker; Henry Völzke; Joey Ward; Jill P. Pell; Tom Meade; Ingrid E. Christophersen; Anke H. Maitland-van der Zee; Ekaterina V. Baranova; Robin Young; Ian Ford; Archie Campbell; Sandosh Padmanabhan; Michiel L. Bots; Diederick E. Grobbee; Philippe Froguel; Dorothée Thuillier; Ronan Roussel; Amélie Bonnefond; Bertrand Cariou; Melissa Smart; Yanchun Bao; Meena Kumari; Anubha Mahajan; Jemma C. Hopewell; Sudha Seshadri; the METASTROKE Consortium of the ISGC; Caroline Dale; Rui Providencia E. Costa; Paul M. Ridker; Daniel I. Chasman; Alex P. Reiner; Marylyn D. Ritchie; Leslie A. Lange; Alex J. Cornish; Sara E. Dobbins; Kari Hemminki; Ben Kinnersley; Marc Sanson; Karim Labreche; Matthias Simon; Melissa Bondy; Philip Law; Helen Speedy; James Allan; Ni Li; Molly Went; Niels Weinhold; Gareth Morgan; Pieter Sonneveld; Björn Nilsson; Hartmut Goldschmidt; Amit Sud; Andreas Engert; Markus Hansson; Harry Hemingway; Folkert W. Asselbergs; Riyaz S. Patel; Brendan J. Keating; Naveed Sattar; Richard Houlston; Juan P. Casas; Aroon D. Hingorani

BMC Cardiovascular Disorders, Vol 19, Iss 1, Pp 1-10 (2019)

Arias V; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Kudling TV; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Clubb JHA; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; TILT Biotherapeutics Ltd, Helsinki, Finland.; Jirovec E; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Pakola SA; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Van der Heijden M; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Basnet S; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Quixabeira DCA; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; TILT Biotherapeutics Ltd, Helsinki, Finland.; Haybout L; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; TILT Biotherapeutics Ltd, Helsinki, Finland.; Ojala N; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Grönberg-Vähä-Koskela S; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Comprehensive Cancer Center, Helsinki University Hospital (HUS), Helsinki, Finland.; Kanerva A; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Department of Obstetrics and Gynecology, Helsinki University Central Hospital (HUS), Helsinki, Finland.; Rannikko A; Department of Urology, Helsinki University Hospital (HUS), Helsinki, Finland.; ONCOSYS Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Santos JM; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; TILT Biotherapeutics Ltd, Helsinki, Finland.; Cervera-Carrascon V; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; TILT Biotherapeutics Ltd, Helsinki, Finland.; Hemminki O; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Department of Urology, Helsinki University Hospital (HUS), Helsinki, Finland.; Hemminki A; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; TILT Biotherapeutics Ltd, Helsinki, Finland.; Comprehensive Cancer Center, Helsinki University Hospital (HUS), Helsinki, Finland.

Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9918752083706676 Publication Model: eCollection Cited Medium: Print ISSN: 2950-3299 (Print) Linking ISSN: 29503299 NLM ISO Abbreviation: Mol Ther Oncol Subsets: PubMed not MEDLINE

Tichanek F; Biomedical Center, Faculty of Medicine in Pilsen, Charles University in Prague, Alej Svobody 76, 30605 Pilsen, Czech Republic.; Institute of Pathological Physiology, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.; Försti A; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.; Liska V; Biomedical Center, Faculty of Medicine in Pilsen, Charles University in Prague, Alej Svobody 76, 30605 Pilsen, Czech Republic.; Department of Surgery, University Hospital, Faculty of Medicine in Pilsen, Charles University in Prague, 30605 Pilsen, Czech Republic.; Hemminki O; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Finland.; Department of Urology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.; Koskinen A; Department of Otorhinolaryngology-Head and Neck Surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.; Hemminki A; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Finland.; Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland.; Hemminki K; Biomedical Center, Faculty of Medicine in Pilsen, Charles University in Prague, Alej Svobody 76, 30605 Pilsen, Czech Republic.; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, D-69120 Heidelberg, Germany.

Publisher: Oxford University Press Country of Publication: England NLM ID: 9423848 Publication Model: Print Cited Medium: Internet ISSN: 1479-683X (Electronic) Linking ISSN: 08044643 NLM ISO Abbreviation: Eur J Endocrinol Subsets: MEDLINE

C. Cybulski; W. Kluźniak; T. Huzarski; D. Wokołorczyk; A. Kashyap; A. Jakubowska; M. Szwiec; T. Byrski; T. Dębniak; B. Górski; V. Sopik; M. R. Akbari; P. Sun; J. Gronwald; S. A. Narod; J. Lubiński; D. Dymerska; G. Kurzawski; K. Tutlewska; M. Kuswik; H. Rudnicka; R. J. Scott; R. Billings; A. Pławski; J. Lubinski; T. Gromowski; K. Kąklewski; W. Marciniak; K. Durda; M. Lener; G. Sukiennicki; K. Kaczmarek; K. Jaworska-Bieniek; K. Paszkowska-Szczur; P. Waloszczyk; K. Hemminki; A. Försti; O. Oszurek; K. Gugała; M. Stawicka; Z. Morawiec; T. Mierzwa; M. Falco; H. Janiszewska; E. Kilar; E. Marczyk; B. Kozak-Klonowska; M. Siołek; D. Surdyka; R. Wiśniowski; M. Posmyk; P. Domagała; Polish Breast Cancer Consortium; E. N. Imyanitov; M. Muszyńska; K. Prajzendanc; N. Peruga; A. Morawski; M. R. Lener; P. Baszuk; A. Wiechowska-Kozłowska; J. Kładny; S. Pietrzak; A. Soluch; A. Plawski; U. R. Rashid; H. Naeemi; N. Muhammad; A. Loya; M. A. Yusuf; A. Savanevich; O. Aszurek; A. Mathe; M. Wong-Brown; W. Locke; C. Stirzaker; S. G. Braye; J. F. Forbes; S. Clark; K. Avery-Kiejda; J. Tomiczek-Szwiec; J. Jakubowicz; R. Sibilski; R. Posmyk

Hereditary Cancer in Clinical Practice, Vol 15, Iss S2, Pp 1-6 (2017)

Vitug C; Division of Urology, Department of Surgery, Mount Sinai Hospital, Sinai Health System, Toronto, Ontario, Canada.; Lajkosz K; Department of Biostatistics, University Health Network, Toronto, Ontario, Canada.; Chavarriaga J; Division of Urology, Department of Surgery, Mount Sinai Hospital, Sinai Health System, Toronto, Ontario, Canada.; Divisions of Urology and Surgical Oncology, Department of Surgery, University Health Network, Toronto, Ontario, Canada.; Llano A; Division of Urology, Department of Surgery, Mount Sinai Hospital, Sinai Health System, Toronto, Ontario, Canada.; Din S; Division of Urology, Department of Surgery, Mount Sinai Hospital, Sinai Health System, Toronto, Ontario, Canada.; Villegas E; Division of Urology, Department of Surgery, Mount Sinai Hospital, Sinai Health System, Toronto, Ontario, Canada.; Kuk C; Division of Urology, Department of Surgery, Mount Sinai Hospital, Sinai Health System, Toronto, Ontario, Canada.; Divisions of Urology and Surgical Oncology, Department of Surgery, University Health Network, Toronto, Ontario, Canada.; Chan A; Division of Urology, Department of Surgery, Mount Sinai Hospital, Sinai Health System, Toronto, Ontario, Canada.; Gao B; Divisions of Urology and Surgical Oncology, Department of Surgery, University Health Network, Toronto, Ontario, Canada.; Hemminki O; Divisions of Urology and Surgical Oncology, Department of Surgery, University Health Network, Toronto, Ontario, Canada.; Kot D; Divisions of Urology and Surgical Oncology, Department of Surgery, University Health Network, Toronto, Ontario, Canada.; Misurka J; Divisions of Urology and Surgical Oncology, Department of Surgery, University Health Network, Toronto, Ontario, Canada.; van der Kwast TH; Department of Pathology, University Health Network, Toronto, Ontario, Canada.; Wallis C; Division of Urology, Department of Surgery, Mount Sinai Hospital, Sinai Health System, Toronto, Ontario, Canada.; Jewett MAS; Divisions of Urology and Surgical Oncology, Department of Surgery, University Health Network, Toronto, Ontario, Canada.; Soloway MS; Division of Urology, Memorial Physician Group, Memorial Healthcare System, Hollywood, FL, USA.; Fleshner NE; Divisions of Urology and Surgical Oncology, Department of Surgery, University Health Network, Toronto, Ontario, Canada.; Kulkarni GS; Divisions of Urology and Surgical Oncology, Department of Surgery, University Health Network, Toronto, Ontario, Canada.; Zlotta AR; Division of Urology, Department of Surgery, Mount Sinai Hospital, Sinai Health System, Toronto, Ontario, Canada.; Divisions of Urology and Surgical Oncology, Department of Surgery, University Health Network, Toronto, Ontario, Canada.

Publisher: Blackwell Science Country of Publication: England NLM ID: 100886721 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-410X (Electronic) Linking ISSN: 14644096 NLM ISO Abbreviation: BJU Int Subsets: MEDLINE

Rebullar, K.; Hemminki, O.; Skeldon, S.; Semotiuk, K.; Aronson, M.; Kuk, C.; Lajkosz, K.; Gallinger, S.; Cohen, Z.; Zlotta, A.R.

European Urology. 79:S1002-S1002

Saunders, Charlie N.; Chattopadhyay, Subhayan; Huhn, Stefanie; Weinhold, Niels; Hoffmann, Per; Nöthen, Markus M.; Jöckel, Karl-Heinz; Schmidt, Börge; Landi, Stefano; Goldschmidt, Hartmut; Milani, Paolo; Merlini, Giampaolo; Rowcieno, Dorota; Hawkins, Philip; Hegenbart, Ute; Palladini, Giovanni; Wechalekar, Ashutosh; Schönland, Stefan O.; Försti, Asta; Houlston, Richard; Hemminki, Kari

Blood Advances. 5(13):2725-2731

Kudling TV; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Clubb JHA; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; TILT Biotherapeutics Ltd, Helsinki, Finland.; Pakola S; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Quixabeira DCA; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; TILT Biotherapeutics Ltd, Helsinki, Finland.; Lähdeniemi IAK; Translational Lung Cancer Research Group, Institute for Molecular Medicine Finland (FIMM), HiLife, University of Helsinki, Helsinki, Finland.; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland.; Heiniö C; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Arias V; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Havunen R; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; TILT Biotherapeutics Ltd, Helsinki, Finland.; Cervera-Carrascon V; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; TILT Biotherapeutics Ltd, Helsinki, Finland.; Santos JM; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; TILT Biotherapeutics Ltd, Helsinki, Finland.; Sutinen E; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland.; Individualized Drug Therapy Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Department of Pulmonary Medicine, Heart and Lung Center, Helsinki University Hospital, Helsinki, Finland.; Räsänen J; General Thoracic and Esophageal Surgery, Heart and Lung Center, Helsinki University Hospital and Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Borenius K; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland.; General Thoracic and Esophageal Surgery, Heart and Lung Center, Helsinki University Hospital and Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Mäyränpää MI; Pathology, University of Helsinki and Helsinki University Hospital (HUSLAB), Helsinki, Finland.; Aaltonen E; Faculty of Medicine, Medicum, University of Helsinki, Helsinki, Finland.; Sorsa S; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; TILT Biotherapeutics Ltd, Helsinki, Finland.; Hemminki O; Comprehensive Cancer Center, Helsinki University Hospital (HUS), Helsinki, Finland.; Department of Urology, Helsinki University Hospital, Helsinki, Finland.; Kanerva A; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Comprehensive Cancer Center, Helsinki University Hospital (HUS), Helsinki, Finland.; Department of Gynecology and Obstetrics, Helsinki University Hospital, Helsinki, Finland.; Verschuren EW; Translational Lung Cancer Research Group, Institute for Molecular Medicine Finland (FIMM), HiLife, University of Helsinki, Helsinki, Finland.; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland.; Ilonen I; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland.; General Thoracic and Esophageal Surgery, Heart and Lung Center, Helsinki University Hospital and Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Hemminki A; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; TILT Biotherapeutics Ltd, Helsinki, Finland.; Comprehensive Cancer Center, Helsinki University Hospital (HUS), Helsinki, Finland.

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE